Kwizda Pharma is part of the Kwizda Group and is active worldwide. We focus on developing, manufacturing and promoting innovative brand-name over–the-counter products as well as medications requiring a prescription in the therapeutic areas: cough and cold treatment, bladder health and pain management as well as addressing hypertension, gastroenterology, osteoporosis and gynecological conditions.
Lactosan is one of the leading manufacturers of products with living lactic acid bacteria. We offer process development, contract manufacturing of microorganisms and enzymes on different scales, freeze-drying and filling in various containers. The core business is the production and formulation of probiotics in animal food and the production of starter cultures for silages. Additionally, microorganisms and enzymes intended for technical applications and human use are part of our portfolio.
Lexogen is a leading company in RNA sequencing, providing innovative solutions for transcriptome analysis and RNA research. Our products and services are designed to meet the evolving needs of the scientific community, delivering end-to-end solutions for high-quality, reliable results. For more information, visit Lexogen website: www.lexogen.com and follow @lexogen.
Lignovations has developed a patented process to manufacture functional ingredients for cosmetics, coatings, packaging, and more from upcycled biomass. By transforming lignin, a component of biomass that protects the plant into so-called ‚Colloidal Lignin Particles’, Lignovations high-performance bio-material can replace non-renewable ingredients, such as UV filters, antioxidants, and emulsifiers that are harmful to human health and the environment.
Livin Farms Hive PRO Factory is a modular, plug-and-play insect farming factory that can turn industrial amounts of organic waste by-products into insect proteins. Those can in turn be processed and sold as animal feed. “We are using insects´ key function in the ecosystem to make our food system healthy again at scale: Turning waste into precious food!” (Katharina Unger, CEO).
Marinomed Biotech AG is a biopharmaceutical company focused on inventing, developing, and partnering clinically meaningful therapies for patients suffering from serious viral infectious diseases and autoreactive immune disorders. Since its foundation in 2006, Marinomed has launched two powerful technologies (Carragelose® and Marinosolv®) with promising product candidates in the pipeline and a great potential for developing drugs that target diseases with high unmet medical need.
Unsere Experten im Bereich Life Science unterstützen Wissenschaftler und Ingenieure dabei, die Herausforderungen in jedem Entwicklungsstadium ihrer Arbeit zu meistern. Unser Angebot umfasst fortschrittlichste Technologien sowie hochwertige Produkte und Lösungen. Anwendung finden diese in der F
We are a global healthcare company with a history of more than 125 years, dedicated to improving patients' lives. Our mission is to discover, develop and deliver products and services that help people and animals around the world live healthier lives.
Microsynth Austria is an Austrian subsidiary of Microsynth AG and is located at the Biotechnology Center in Vienna. The parent company has it's headquarter in Balgach, Switzerland, and operates further subsidiaries in Germany (Microsynth Seqlab) and France (Microsynth France). Altogether Microsynth employs a staff of more than 100 people.
Our mission is to provide solutions for the recombinant production of alternative proteins and enzymes. Precision fermentation allows us to create smart materials. To produce our proteins, we build on yeasts such as Pichia pastoris. Building on license-free tools and own developments we have established or own toolbox for production. To produce our proteins, we build on methanol-free processes.
At Myllia, we perform pooled CRISPR screens and functional genomics at scale in advanced cellular models to map the impact of thousands of genetic perturbations at single-cell resolution – a new paradigm to nominate the best possible targets for your drug discovery campaign. Pooled CRISPR screens accelerate drug discovery across many therapeutic areas and help unravel gene regulatory networks in cancer cells and primary human T cells.
Nagene specializes in the production of custom DNA sequences through advanced gene synthesis technologies. We serve the pharmaceutical and biotechnology sectors, providing precise, high-quality DNA products that support research, development, and therapeutic applications, including mRNA therapies and personalized medicine.